1. Small-molecule inhibitors targeting FOXM1: Current challenges and future perspectives in cancer treatments
   Sanjeev Raghuwanshi et al, 2023, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
2. Casticin as potential anticancer agent: recent advancements in multi-mechanistic approaches
   Katya Carbone et al, 2023, Frontiers in Molecular Biosciences CrossRef
3. Unveiling promising bioactives for breast cancer: a novel approach for herbal-based drug discovery
   Aditya Arvindekar et al, 2024, Phytochemistry Reviews CrossRef
4. Modulation of oncogenic transcription factors by bioactive natural products in breast cancer
   Mohadeseh Hasanpourghadi et al, 2018, Pharmacological Research CrossRef
5. Casticin prevents DSS induced ulcerative colitis in mice through inhibitions of NF‐κB pathway and ROS signaling
   Jiamei Ma et al, 2018, Phytotherapy Research CrossRef
6. Casticin induces DNA damage and inhibits DNA repair-associated protein expression in B16F10 mouse melanoma cancer cells
   Yung-Luen Shih et al, 2016, Oncology Reports CrossRef
7. Casticin inhibits breast cancer cell migration and invasion by down-regulation of PI3K/Akt signaling pathway
   Li Fan et al, 2018, Bioscience Reports CrossRef
8. Chrysosplenol d, a Flavonol from Artemisia annua, Induces ERK1/2-Mediated Apoptosis in Triple Negative Human Breast Cancer Cells
   Sophia J. Lang et al, 2020, International Journal of Molecular Sciences CrossRef
9. Breast Cancer: a Global Concern, Diagnostic and Therapeutic Perspectives, Mechanistic Targets in Drug Development
   Gul-e-Saba Chaudhry et al, 2020, Advanced Pharmaceutical Bulletin CrossRef
10. Casticin Impacts Key Signaling Pathways in Colorectal Cancer Cells Leading to Cell Death with Therapeutic Implications
    Michael Kowalski et al, 2022, Genes CrossRef
11. FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
    Dhanya Kalathil et al, 2021, Frontiers in Oncology CrossRef
12. An Update on the Effect of Natural Products on Oncogenic Transcription Factors in Triple Negative Breast Cancer
    Ashwathi Vijayalekha et al, 2022, Handbook of Research on Natural Products and Their Bioactive Compounds as Cancer Therapeutics CrossRef
13. Flavonoids as Inducers of Apoptosis and Autophagy in Breast Cancer
    Didem Şöhretoğlu et al, 2021, Discovery and Development of Anti-Breast Cancer Agents from Natural Products CrossRef
14. Tetramethylpyrazine inhibits prostate cancer progression by downregulation of forkhead box M1
    Yi Zhou et al, 2017, Oncology Reports CrossRef
15. Casticin from Vitex species: a short review on its anticancer and anti-inflammatory properties
    Eric Wei Chiang Chan et al, 2018, Journal of Integrative Medicine CrossRef
16. The Role of Forkhead Box Protein M1 in Breast Cancer Progression and Resistance to Therapy
    Raya Saba et al, 2016, International Journal of Breast Cancer CrossRef
17. Breast tissue–based microRNA panel highlights microRNA-23a and selected target genes as putative biomarkers for breast cancer
    Sanaa Eissa et al, 2015, Translational Research CrossRef
18. Casticin inhibits esophageal cancer cell proliferation and promotes apoptosis by regulating mitochondrial apoptotic and JNK signaling pathways
    Zhe Qiao et al, 2019, Naunyn-Schmiedeberg's Archives of Pharmacology CrossRef
19. A review of Viticis Fructus: botany, historical records, phytochemistry, pharmacology, toxicity, quality control, pharmacokinetics and comprehensive applications
    Xue Meng et al, 2024, Arabian Journal of Chemistry CrossRef